| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Estradiol | FAERS: 11 | US FAERS | |
| 2 | Simbrinza | FAERS: 8 | US FAERS | |
| 3 | Testosterone | FAERS: 8 | US FAERS | |
| 4 | nepafenac | FAERS: 7 | US FAERS | |
| 5 | Buprenorphine | FAERS: 5 | US FAERS | |
| 6 | Diclofenac | FAERS: 4 | US FAERS | |
| 7 | Estrogens, Conjugated (USP) | FAERS: 4 | US FAERS | |
| 8 | Clopidogrel | FAERS: 3 | US FAERS | |
| 9 | insulin aspart, insulin aspart protamine drug combination 30:70 | FAERS: 2 | US FAERS | |
| 10 | Estradiol acetate | FAERS: 1 | US FAERS | |
| 11 | Lidocaine | FAERS: 1 | US FAERS | |
| 12 | Lidoderm | FAERS: 1 | US FAERS | |
| 13 | difluprednate | FAERS: 1 | US FAERS | |
| 14 | treprostinil | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.